/Equipment%20and%20medical%20devices%20in%20hybrid%20operating%20room%20by%20%E5%AE%89%E7%90%A6%20%E7%8E%8B%20via%20Adobe%20Stock.jpeg)
Insulet Corporation (PODD), headquartered in Acton, Massachusetts, operates as an innovative medical device company. Valued at $9.7 billion by market cap, the company develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
Companies worth $2 billion or more are generally described as “mid-cap stocks,” and PODD fits right into that category with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical devices industry. PODD drives innovation through heavy investment in R&D, focusing on user-friendly diabetes solutions. With a customer-centric approach, the company provides comprehensive support services and engages with the diabetes community. PODD is expanding globally, entering new markets and establishing distribution channels to increase its international presence.
